

VC Investing at CRV with James Green
Nov 20, 2024
James Green, a general partner at CRV, shares his journey from studying neuroscience at Harvard to venture capital, highlighting how tech and health intersect. He discusses the importance of early-stage startups in driving innovation and how unique insights are key to gaining competitive advantages. The conversation also delves into the intricacies of pre-seed investments, stressing the value of revenue potential over initial metrics, and evaluates the emerging landscape of AI applications in the tech industry.
AI Snips
Chapters
Books
Transcript
Episode notes
James Green's Path to VC
- James Green's path to VC involved neuroscience, realizing the US pharma system's flaws, and transitioning to tech.
- He scraped emails, worked at CarWow, and interned at Inside Partners before starting his own company.
High-Leverage Points
- High-leverage points are crucial moments in a company's life, like turning down acquisition offers or adapting to tech shifts.
- VCs help navigate these points, drawing from experience with other companies.
Adobe's Success
- Adobe, while not perceived as 'cool', successfully navigated multiple high-leverage points, like the shift to cloud software.
- Their adoption of generative AI further exemplifies their ability to adapt and stay relevant.